PMID: 9443524Jan 1, 1997Paper

A study of enhanced management in patients with treatment-resistant schizophrenia

Journal of Psychopharmacology
G MercerD G Owens

Abstract

The clinical efficacy of two intensive treatment packages (one including the new antipsychotic risperidone and the other not doing so) was compared with that of standard management in 43 patients with long-standing treatment-resistant schizophrenia. Significant differences between the groups in terms of total positive or total negative symptoms were not demonstrated, but the pattern of change between the treatment groups differed, so that benefit in positive symptomatology was seen in both intensive treatment groups and in negative symptomatology in the intensive treatment/risperidone group and the standard group. Changes in general psychopathology were most marked in the risperidone group and were compatible with a relatively non-sedative profile. Using the Disability Assessment Schedule, substantial significant advantages for the intensive treatment groups were found.

References

Sep 1, 1979·The Journal of Nervous and Mental Disease·A H Tuma, P R May
Feb 1, 1976·The American Journal of Psychiatry·J M Davis
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·J F MacMillanE C Johnstone
Jan 1, 1987·Schizophrenia Bulletin·R L Morrison, A S Bellack
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1972·Archives of General Psychiatry·J P FeighnerR Munoz
Jan 1, 1982·Schizophrenia Bulletin·R P Liberman
Sep 1, 1980·Comprehensive Psychiatry·J D WojcikM Mieske
Jun 1, 1994·The American Journal of Psychiatry·S R Marder, R C Meibach
Sep 23, 1995·Lancet·J M Kane, T H McGlashan

❮ Previous
Next ❯

Citations

Apr 29, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Myrto T SamaraStefan Leucht

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
Julie KreyenbuhlMark Olfson
Progress in Neuro-psychopharmacology & Biological Psychiatry
Istvan BitterOlanzapine HGCK Study Group
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
V A Curtis, R W Kerwin
© 2021 Meta ULC. All rights reserved